CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Platelet rich plasma (PRP)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02397278
NCT02397278N/ACompleted
CompareCT.gov

Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee: Does it Help? A Clinical and Magnetic Resonance Imaging (MRI) Study.

University of Colorado, Denver·interventional·Posted Mar 24, 2015·Updated Aug 5, 2021

In Brief

A clinical study evaluating Platelet rich plasma (PRP) for Osteochondritis Dissecans. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This study plans to learn more about ways to treat a joint problem in the knee called Juvenile Osteochondritis Dissecans (OCD). The goal of this study is to see if injecting platelet-rich plasma (PRP) into the knee can help knee cartilage heal faster, and will try to determine whether the injections lead to improvements in pain, performance of activities of daily living, improvements is sports activities and overall function and symptoms reduction. The investigators will compare PRP treatment to conservative therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteochondritis Dissecans
CountriesUnited States
CollaboratorsTerumo BCT

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 24, 2015
Enrollment StartMar 1, 2015
Primary CompletionJan 8, 2020
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 11.3 years ago

Interventions

Platelet rich plasma (PRP)drug

Patient will receive 3 intra articular injections with autologous PRP in the affected knee and then follow conventional therapy.